Jian‐Wu Yu

Predictive value of rapid virological response and early virological response on sustained virological response in HCV patients treated with pegylated interferon α‐2a and ribavirin

Jian‐Wu Yu, Gui‐Qiang Wang, Lijie Sun et al. · Journal of Gastroenterology and Hepatology · 2007 · 129 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double‐blind, placebo‐controlled trials

Philip Schoenfeld, Mark Pimentel, Lin Chang et al. · Alimentary Pharmacology & Therapeutics · 2014 · 101 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Influential factors of prognosis in lamivudine treatment for patients with acute‐on‐chronic hepatitis B liver failure

Lijie Sun, Jian‐Wu Yu, Yonghua Zhao et al. · Journal of Gastroenterology and Hepatology · 2009 · 74 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

The Study of Efficacy of Lamivudine in Patients with Severe Acute Hepatitis B

Jian‐Wu Yu, Lijie Sun, Yong-Hua Zhao et al. · Digestive Diseases and Sciences · 2009 · 71 citations

Pharmacy, Pharmacokinetics, Pharmacology +12

Hepatitis C virus core protein induces hepatic metabolism disorders through down-regulation of the SIRT1–AMPK signaling pathway

Jian‐Wu Yu, Lijie Sun, Wei Liu et al. · International Journal of Infectious Diseases · 2013 · 60 citations · Full text

Life Sciences, Biochemistry, Cell Biology +17